KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Inventory Average: 2009-2025

Historic Inventory Average for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to $3.4 billion.

  • Teva Pharmaceutical Industries' Inventory Average fell 13.52% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year decrease of 13.52%. This contributed to the annual value of $3.5 billion for FY2024, which is 10.52% down from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Inventory Average of $3.4 billion as of Q3 2025, which was up 1.13% from $3.4 billion recorded in Q2 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Inventory Average peaked at $4.4 billion during Q1 2021, and registered a low of $3.1 billion during Q1 2025.
  • Its 3-year average for Inventory Average is $3.8 billion, with a median of $3.9 billion in 2024.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Inventory Average rose by 4.94% in 2023, and later decreased by 21.53% in 2025.
  • Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Inventory Average stood at $4.0 billion in 2021, then dropped by 3.67% to $3.8 billion in 2022, then grew by 4.94% to $4.0 billion in 2023, then decreased by 13.70% to $3.5 billion in 2024, then fell by 13.52% to $3.4 billion in 2025.
  • Its Inventory Average stands at $3.4 billion for Q3 2025, versus $3.4 billion for Q2 2025 and $3.1 billion for Q1 2025.